LEO Pharma is a leader in medical dermatology with a robust R&D pipeline across a wide range of therapies enabling people with severe skin diseases to access medicine and treatment.
Company Background
- Advancing the science of dermatology with a leading branded topical dermatology franchise based on decades of research and development.
- Setting new standards of care for people with skin conditions with a global team of about 5,000 people, serving 93 million patients in more than 130 countries.
Vision & Outlook
- Support LEO Pharma on its journey to strengthening its global leadership in medical dermatology.
- Help to expand the company's dermatology franchise and to accelerate innovation and growth.
Highlights & Updates
- Committed to net-zero climate target aligned with SBTi and launched ESG linked financing.
SECTOR
Healthcare
REVENUES 2022
EUR 1,430 million
EMPLOYEES
5,045
OWNERSHIP
Fund X
INVESTMENT DATE
2021
HEAD OFFICE
Ballerup, Denmark
